Please login to the form below

Not currently logged in
Email:
Password:

Tamiflu

This page shows the latest Tamiflu news and features for those working in and with pharma, biotech and healthcare.

Roche’s new flu pill Xofluza approved in US

Roche’s new flu pill Xofluza approved in US

including those resistant to Roche’s now off-patent and former blockbuster flu treatment, Tamiflu. ... Xofluza is given as a convenient single (one time) dose compared to Tamiflu’s twice daily dosing.

Latest news

  • Encouraging data for Roche flu drug ahead of FDA decision Encouraging data for Roche flu drug ahead of FDA decision

    Tamiflu was a multi-billion dollar earner just a few years ago, but generic versions have now flooded onto the market. ... The pipeline drug will have to significantly outperform the now generic Tamiflu to gain traction.

  • Roche’s Tamiflu successor hits the mark in complicated flu Roche’s Tamiflu successor hits the mark in complicated flu

    It also achieved secondary objectives, including reducing viral shedding and the amount of virus in the body compared to placebo and also Roche’s established flu drug Tamiflu (oseltamivir). ... Roche introduced its mainstay flu drug Tamiflu (oseltamivir

  • Long-serving R&D head Bischofberger to leave Gilead Long-serving R&D head Bischofberger to leave Gilead

    Austria-born Bischofberger - who rose to prominence as one of the inventors of Roche’s big-selling influenza drug Tamiflu (oseltamivir) - will leave the company fully in July after 28 years

  • The state of trust The state of trust

    Roche has a mixed background in this area. Its reticence over publishing clinical studies for its flu drug Tamiflu was one of the drivers behind the formation of AllTrials in 2013.

  • Tecentriq growth offsets Avastin's US decline at Roche Tecentriq growth offsets Avastin's US decline at Roche

    Roche is expecting some pressure in 2017 thanks in part to the loss of US patent protection for influenza drug Tamiflu (oseltamivir) in December 2016, exposing around $500m of the

More from news
Approximately 6 fully matching, plus 89 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Solaris Health

The beauty of detail: an effective, compelling medical communications campaign requires each component to be carefully planned, expertly crafted and...

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics